Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.53 USD | -0.09% | +4.17% | +32.92% |
19/04 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
01/04 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |